The Use of Heparin during Endovascular Peripheral Arterial Interventions: A Synopsis
A large variety exists for many aspects of the use of heparin as periprocedural prophylactic antithrombotics (PPAT) during peripheral arterial interventions (PAI). This variation is present, not only within countries, but also between them. Due to a lack of (robust) data, no systematic review on the...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Scientifica |
| Online Access: | http://dx.doi.org/10.1155/2016/1456298 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832564103665680384 |
|---|---|
| author | Arno M. Wiersema Christopher Watts Alexandra C. Durran Michel M. P. J. Reijnen Otto M. van Delden Frans L. Moll Jan Albert Vos |
| author_facet | Arno M. Wiersema Christopher Watts Alexandra C. Durran Michel M. P. J. Reijnen Otto M. van Delden Frans L. Moll Jan Albert Vos |
| author_sort | Arno M. Wiersema |
| collection | DOAJ |
| description | A large variety exists for many aspects of the use of heparin as periprocedural prophylactic antithrombotics (PPAT) during peripheral arterial interventions (PAI). This variation is present, not only within countries, but also between them. Due to a lack of (robust) data, no systematic review on the use of heparin during PAI could be justified. A synopsis of all available literature on heparin during PAI describes that heparin is used on technical equipment to reduce the thrombogenicity and in the flushing solution with saline. Heparin could have a cumulative anticoagulant effect when used in combination with ionic contrast medium. No level-1 evidence exists on the use of heparin. A measurement of actual anticoagulation status by means of an activated clotting time should be mandatory. |
| format | Article |
| id | doaj-art-0c585eab758542d9b41da060049073b7 |
| institution | Kabale University |
| issn | 2090-908X |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Scientifica |
| spelling | doaj-art-0c585eab758542d9b41da060049073b72025-02-03T01:11:48ZengWileyScientifica2090-908X2016-01-01201610.1155/2016/14562981456298The Use of Heparin during Endovascular Peripheral Arterial Interventions: A SynopsisArno M. Wiersema0Christopher Watts1Alexandra C. Durran2Michel M. P. J. Reijnen3Otto M. van Delden4Frans L. Moll5Jan Albert Vos6Department of Surgery, Division of Vascular Surgery, Westfriesgasthuis, Maelsonstraat 3, 1624 NP Hoorn, NetherlandsDepartment of Radiology, Salisbury District Hospital, Odstock Road, Salisbury, Wiltshire SP2 8BJ, UKDepartment of Radiology, Peninsula Radiology Academy, Plymouth PL6 5WR, UKDepartment of Surgery, Rijnstate Hospital, Arnhem, Postbus 9555, 6800 TA Arnhem, NetherlandsDepartment of Radiology, Division of Interventional Radiology, Academic Medical Centre, University of Amsterdam, Postbus 22660, 1100 DD Amsterdam, NetherlandsDepartment of Surgery, Division of Vascular Surgery, University Medical Centre Utrecht, University of Utrecht, Postbus 85500, 3508 GA Utrecht, NetherlandsDepartment of Radiology, Division of Interventional Radiology, St. Antonius Hospital, Postbus 2500, 3430 EM Nieuwegein, NetherlandsA large variety exists for many aspects of the use of heparin as periprocedural prophylactic antithrombotics (PPAT) during peripheral arterial interventions (PAI). This variation is present, not only within countries, but also between them. Due to a lack of (robust) data, no systematic review on the use of heparin during PAI could be justified. A synopsis of all available literature on heparin during PAI describes that heparin is used on technical equipment to reduce the thrombogenicity and in the flushing solution with saline. Heparin could have a cumulative anticoagulant effect when used in combination with ionic contrast medium. No level-1 evidence exists on the use of heparin. A measurement of actual anticoagulation status by means of an activated clotting time should be mandatory.http://dx.doi.org/10.1155/2016/1456298 |
| spellingShingle | Arno M. Wiersema Christopher Watts Alexandra C. Durran Michel M. P. J. Reijnen Otto M. van Delden Frans L. Moll Jan Albert Vos The Use of Heparin during Endovascular Peripheral Arterial Interventions: A Synopsis Scientifica |
| title | The Use of Heparin during Endovascular Peripheral Arterial Interventions: A Synopsis |
| title_full | The Use of Heparin during Endovascular Peripheral Arterial Interventions: A Synopsis |
| title_fullStr | The Use of Heparin during Endovascular Peripheral Arterial Interventions: A Synopsis |
| title_full_unstemmed | The Use of Heparin during Endovascular Peripheral Arterial Interventions: A Synopsis |
| title_short | The Use of Heparin during Endovascular Peripheral Arterial Interventions: A Synopsis |
| title_sort | use of heparin during endovascular peripheral arterial interventions a synopsis |
| url | http://dx.doi.org/10.1155/2016/1456298 |
| work_keys_str_mv | AT arnomwiersema theuseofheparinduringendovascularperipheralarterialinterventionsasynopsis AT christopherwatts theuseofheparinduringendovascularperipheralarterialinterventionsasynopsis AT alexandracdurran theuseofheparinduringendovascularperipheralarterialinterventionsasynopsis AT michelmpjreijnen theuseofheparinduringendovascularperipheralarterialinterventionsasynopsis AT ottomvandelden theuseofheparinduringendovascularperipheralarterialinterventionsasynopsis AT franslmoll theuseofheparinduringendovascularperipheralarterialinterventionsasynopsis AT janalbertvos theuseofheparinduringendovascularperipheralarterialinterventionsasynopsis AT arnomwiersema useofheparinduringendovascularperipheralarterialinterventionsasynopsis AT christopherwatts useofheparinduringendovascularperipheralarterialinterventionsasynopsis AT alexandracdurran useofheparinduringendovascularperipheralarterialinterventionsasynopsis AT michelmpjreijnen useofheparinduringendovascularperipheralarterialinterventionsasynopsis AT ottomvandelden useofheparinduringendovascularperipheralarterialinterventionsasynopsis AT franslmoll useofheparinduringendovascularperipheralarterialinterventionsasynopsis AT janalbertvos useofheparinduringendovascularperipheralarterialinterventionsasynopsis |